Lysophosphatidylcholine enhances NGF-induced MAPK and Akt signals through the extracellular domain of TrkA in PC12 cells

FEBS Open Bio

Volumn 3, Issue , 2013, Pages 243-251

  Wuhanqimuge, ^a   Itakura, Asako ^a   Matsuki, Yuri ^b   Tanaka, Masato ^b   Arioka, Manabu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO DENKI UNIVERSITY   (Japan)

Author keywords

Akt; Lysophosphatidylcholine; Mitogen activated protein kinase (MAPK); Nerve growth factor; TrkA

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PHOSPHOLIPASE A2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; SOMATOMEDIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STIMULATION; CHIMERA; CONTROLLED STUDY; DNA SYNTHESIS; DNA TRANSFECTION; GRANULE CELL; HYDROLYSIS; IMMUNOBLOTTING; NONHUMAN; ONCOGENE C FOS; PC12 CELL; PHEOCHROMOCYTOMA; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84878810625     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2013.05.003     Document Type: Article

References (47)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987, 237:1154-1162.
2. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982, 1:549-553.
3. Maisonpierre P.C., Belluscio L., Squinto S., Ip N.Y., Furth M.E., Lindsay R.M., Yancopoulos G.D. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990, 247:1446-1451.
4. Ip N.Y., Ibáñez C.F., Nye S.H., McClain J., Jones P.F., Gies D.R., Belluscio L., Le Beau M.M., Espinosa R., Squinto S.P. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:3060-3064.
5. Wiesmann C., de Vos A.M. Nerve growth factor: structure and function. Cell Mol. Life Sci. 2001, 58:748-759.
6. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
7. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 2003, 72:609-642.
8. Allen S.J., Watson J.J., Dawbarn D. The neurotrophins and their role in Alzheimer's disease. Curr. Neuropharmacol. 2011, 9:559-573.
9. Pardon M.C. Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders. Vitam. Horm. 2010, 82:185-200.
10. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141:1117-1134.
11. Shen J., Maruyama I.N. Nerve growth factor receptor TrkA exists as a preformed, yet inactive, dimer in living cells. FEBS Lett. 2011, 585:295-299.
12. Chowdary P.D., Che D.L., Cui B. Neurotrophin signaling via long-distance axonal transport. Annu. Rev. Phys. Chem. 2012, 63:571-594.
13. Dijkmans T.F., van Hooijdonk L.W.A., Schouten T.G., Kamphorst J.T., Fitzsimons C.P., Vreugdenhil E. Identification of new nerve growth factor-responsive immediate-early genes. Brain Res. 2009, 1249:19-33.
14. Wakatsuki S., Arioka M., Dohmae N., Takio K., Yamasaki M., Kitamoto K. Characterization of a novel fungal protein, p15, which induces neuronal differentiation of PC12 cells. J. Biochem. 1999, 126:1151-1160.
15. 2 induce neurite outgrowth in PC12 cells. Biochem. J. 2003, 376:655-666.
16. 2 for cerebellar granule neurons. FEBS Lett. 2005, 579:2693-2701.
17. 2 enzymes. Prostaglandins Other Lipid. Mediat. 2002, 68-9:3-58.
18. 2 structure/function, mechanism, and signaling. J. Lipid Res. 2009, 50(Suppl.):S237-S242.
19. Murakami M., Taketomi Y., Girard C., Yamamoto K., Lambeau G. Emerging roles of secreted phospholipase A2 enzymes: lessons from transgenic and knockout mice. Biochimie 2010, 92:561-582.
20. 2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J. Biol. Chem 2005, 280:28044-28052.
21. Ikeno Y., Cheon S.H., Konno N., Nakamura A., Kitamoto K., Arioka M. Lysophosphatidylcholine protects cerebellar granule neurons from apoptotic cell death. J. Neurosci. Res. 2009, 87:190-199.
22. Rousset X., Vaisman B., Amar M., Sethi A.A., Remaley A.T. Lecithin: cholesterol acyltransferase - from biochemistry to role in cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2009, 16:163-171.
23. Gauster M., Rechberger G., Sovic A., Horl G., Steyrer E., Sattler W., Frank S. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J. Lipid Res. 2005, 46:1517-1525.
24. Schmitz G., Ruebsaamen K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 2010, 208(1):10-18.
25. βγ-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs. Biochem. J 2010, 432. 35-34.
26. Makide K., Kitamura H., Sato Y., Okutani M., Aoki J. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. Prostaglandins Other Lipid Mediat. 2009, 89(3-4):135-139.
27. Ojala P.J., Hirvonen T.E., Hermansson M., Somerharju P., Parkkinen J. Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J. Leukoc. Biol 2007, 82:1501-1509.
28. Riederer M., Ojala P.J., Hrzenjak A., Tritscher M., Hermansson M., Watzer B., Schweer H., Desoye G., Heinemann A., Frank S. Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production. J. Lipid Res. 2010, 51:2957-2966.
29. Brkic L., Riederer M., Graier W.F., Malli R., Frank S. Acyl chain-dependent effect of lysophosphatidylcholine on cyclooxygenase (COX)-2 expression in endothelial cells. Atherosclerosis 2012, 224(2):348-354.
30. Lu X., Kambe F., Cao X., Yamauchi M., Seo H. Insulin-like growth factor-I activation of Akt survival cascade in neuronal cells requires the presence of its cognate receptor in caveolae. Exp. Cell Res. 2008, 314:342-351.
31. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim. Biophys. Acta 2002, 1582:81-88.
32. Inoue M., Xie W., Matsushita Y., Chun J., Aoki J., Ueda H. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 2008, 152(2):296-298.
33. Sevastou I., Kaffe E., Mouratis M.A., Aidinis V. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. Biochim. Biophys. Acta 2013, 1831(1):42-60.
34. Masuda S., Murakami M., Takanezawa Y., Aoki J., Arai H., Ishikawa Y., Ishii T., Arioka M., Kudo I. Neuronal expression and neuritogenic action of group X secreted phospholipase A2. J. Biol. Chem 2005, 280(24):23203-23214.
35. Scott G.A., Jacobs S.E., Pentland A.P. sPLA2-X stimulates cutaneous melanocyte dendricity and pigmentation through a lysophosphatidylcholine-dependent mechanism. J. Invest. Dermatol. 2006, 126(4):855-861.
36. Blondeau N., Lauritzen I., Widmann C., Lazdunski M., Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J. Cereb. Blood Flow Metab. 2002, 22:821-834.
37. Hasegawa H., Lei J., Matsumoto T., Onishi S., Suemori K., Yasukawa M. Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-beta production. Biochem. Biophys. Res. Commun. 2011, 415:526-531.
38. Qiao J., Huang F., Naikawadi R.P., Kim K.S., Said T., Lum H. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 291:L91-L101.
39. Soga T., Ohishi T., Matsui T., Saito T., Matsumoto M., Takasaki J., Matsumoto S., Kamohara M., Hiyama H., Yoshida S., Momose K., Ueda Y., Matsushime H., Kobori M., Furuichi K. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem. Biophys. Res. Commun. 2005, 326(4):744-751.
40. Lee F.S., Chao M.V. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Natl. Acad. Sci. U.S.A. 2001, 98:3555-3560.
41. Lee F.S., Rajagopal R., Kim A.H., Chang P.C., Chao M.V. Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J. Biol. Chem. 2002, 277:9096-9102.
42. Schecterson L.C., Bothwell M. Neurotrophin receptors: old friends with new partners. Dev. Neurobiol. 2010, 70:332-338.
43. Perez P., Coll P.M., Hempstead B.L., Martin-Zanca D., Chao M.V. NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains. Mol. Cell Neurosci. 1995, 6:97-105.
44. Urfer R., Tsoulfas P., O'Connell L., Shelton D.L., Parada L.F., Presta L.G. An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J. 1995, 14:2795-2805.
45. Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999, 401:184-188.
46. Huang C.S., Zhou J., Feng A.K., Lynch C.C., Klumperman J., DeArmond S.J., Mobley W.C. Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J. Biol. Chem. 1999, 274:36707-36714.
47. Mutoh T., Tokuda A., Miyadai T., Hamaguchi M., Fujiki N. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:5087-5091.